A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults

Overview of attention for article published in PLOS ONE, August 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

f1000: 1 research highlight platform

Citations

dimensions_citation: 78 Dimensions

Readers on

mendeley: 76 Mendeley

Summary X Research highlights Dimensions citations

So far, Dimensions has found 78 publications that cite this research output.

78

The most recent citing publications are shown below. View all 78 publications that cite this research output on Dimensions.

Exploring HIV Vaccine Progress in the Pre-Clinical and Clinical Setting: From History to Future Prospects

Article in Viruses (February 2024)

Nanotechnology and nano-sized tools: Newer approaches to circumvent oncolytic adenovirus limitations

Article in Pharmacology & Therapeutics (February 2024)

Chapter 11 Vaccine against RNA viruses

Book chapter (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.